1/7 France has done the first pharmacokinetic (PK) study of HCQ for ICU patients of #COVID19, a fantastic job for dosage optimization.
🔸13 patients, average weight=82.7 kg
🔸46% pts BMI>30
🔸12 on mechanical ventilators
🔸1 on ECMO
🔸30.7% with medium/severe renal dysfunction https://twitter.com/aknappjr/status/1248312523998121985
🔸2 pts had QT prolongations (>500ms ), but not related to HCQ levels.
🔸 Regimen D: 200mgX3/day for 7 days;
PK simulation shows HCQ reached the therapeutic level of 1mg/L on day 2.5 but exceeds 2mg/L (risk of ocular toxicity) on day 5
🔺In this D regimen, the average HCQ dose is ~7.5 mg/kg/day, which is above the well established safe upper limit: 6.5 mg/kg/day; meanwhile, the HCQ blood concentration exceeds the upper safe level: 2mg/L.
🔸Regimen E: 800mg loading dose, 1mg/L can be reached on day 1, then 400mg (~5mg/kg/day) daily for 6 days, blood levels can be maintained in the therapeutic window for 7 days.
🔸Regimen C: 800+600mg day1, then 600mg/day for 4 days, blood levels exceeds 2mg/L after 8 hrs
🔸Another PBPK report also recommends a similar regimen; 400mg/day+loading dose
🔸the lung concentration will reach level ~400 times higher than those in the blood.
🔸if 400mg/day from day 2, the ratio of lung concentration/EC50 will reach 85.4 on day 5,
and 154 on day 10.
🔸In conclusion, considering efficacy and safety, 800mg Qd as a loading dose on 1st day, then 400mg/day Qd for 4-6 days is the optimal dosage regimen for HCQ to treat #COVID2019
🔸 Dosage should be further individualized to WEIGHT, renal and heart condition, etc
You can follow @88549439.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: